التداخل بين دوكسيلامين وبيريدوكسين ودروبيريدول

Possible pharmacodynamic interactions can occur between droperidol and potentially arrhythmogenic agents such as class I or III antiarrhythmics, antihistamines that prolong the QT interval, antimalarials, calcium channel blockers, neuroleptics that prolong the QT interval, and antidepressants.

Following the administration of droperidol, the dose of other CNS depressant drugs should be reduced.

As with other CNS depressant drugs, patients who have received droperidol should have appropriate surveillance.

Concurrent use of alcohol and other CNS depressants (such as hypnotic sedatives and tranquilizers) with doxylamine succinate and pyridoxine hydrochloride delayed-release tablets is not recommended.